Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

SCYNEXIS Completes Chronic Nonclinical Toxicology Studies Supporting Long-Term Administration of Ibrexafungerp

americanpharmaceuticalreviewMay 31, 2019

Tag: SCYNEXIS , Completes , Studies

PharmaSources Customer Service